Alec Machiels

Insider Reports History

Location
New York, NY
Signature
/s/ David Watson, attorney-in-fact for Alec Machiels
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alec Machiels:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Apellis Pharmaceuticals, Inc. Director Common Stock 377K $5.22M $13.85 01 Jan 2025 Direct
Apellis Pharmaceuticals, Inc. Director Common Stock 250K $3.46M $13.85 01 Jan 2025 Indirect Owner (Bauhaus 1 LLC)
Apellis Pharmaceuticals, Inc. Director Common Stock 150K $2.08M $13.85 01 Jan 2025 Indirect Owner (Spouse Trust)
Apellis Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 11.2K $381K $66.30 01 Jan 2025 Direct
Apellis Pharmaceuticals, Inc. Director Common Stock 12K $166K $13.85 01 Jan 2025 Indirect Owner (Owned by Spouse)

Insider Reports Filed by Alec Machiels

Symbol Company Period Transactions Value $ Form Type Role Filing Time
APLS Apellis Pharmaceuticals, Inc. 01 Jan 2025 2 $0 4 Director 03 Jan 2025, 16:23
APLS Apellis Pharmaceuticals, Inc. 01 Jan 2024 2 $344K 4 Director 02 Jan 2024, 16:08
APLS Apellis Pharmaceuticals, Inc. 17 Nov 2023 3 -$56.3K 4 Director 20 Nov 2023, 16:18
APLS Apellis Pharmaceuticals, Inc. 17 Oct 2023 3 -$57.3K 4 Director 18 Oct 2023, 17:43
APLS Apellis Pharmaceuticals, Inc. 18 Sep 2023 3 -$52.9K 4 Director 19 Sep 2023, 18:05
APLS Apellis Pharmaceuticals, Inc. 15 Sep 2023 3 -$53.3K 4 Director 18 Sep 2023, 17:24
APLS Apellis Pharmaceuticals, Inc. 21 Jul 2023 2 $133K 4 Director 24 Jul 2023, 17:01
APLS Apellis Pharmaceuticals, Inc. 20 Jul 2023 2 $134K 4 Director 21 Jul 2023, 16:13
APLS Apellis Pharmaceuticals, Inc. 17 Jul 2023 3 -$77.7K 4 Director 18 Jul 2023, 16:40
APLS Apellis Pharmaceuticals, Inc. 20 Jun 2023 3 -$107K 4 Director 21 Jun 2023, 16:34
APLS Apellis Pharmaceuticals, Inc. 17 May 2023 3 -$107K 4 Director 18 May 2023, 17:12
APLS Apellis Pharmaceuticals, Inc. 17 Apr 2023 3 -$98K 4 Director 18 Apr 2023, 16:30
APLS Apellis Pharmaceuticals, Inc. 17 Mar 2023 3 -$76.7K 4 Director 21 Mar 2023, 16:35
APLS Apellis Pharmaceuticals, Inc. 17 Feb 2023 3 -$62.1K 4 Director 21 Feb 2023, 15:22
APLS Apellis Pharmaceuticals, Inc. 17 Jan 2023 3 -$62.2K 4 Director 19 Jan 2023, 15:55
APLS Apellis Pharmaceuticals, Inc. 01 Jan 2023 2 $0 4 Director 04 Jan 2023, 16:37
APLS Apellis Pharmaceuticals, Inc. 15 Dec 2022 3 -$62.1K 4 Director 19 Dec 2022, 15:37
APLS Apellis Pharmaceuticals, Inc. 15 Nov 2022 3 -$56.7K 4 Director 17 Nov 2022, 15:33
APLS Apellis Pharmaceuticals, Inc. 14 Oct 2022 3 -$70.8K 4 Director 17 Oct 2022, 17:57
APLS Apellis Pharmaceuticals, Inc. 15 Sep 2022 3 -$79.2K 4 Director 16 Sep 2022, 16:03
APLS Apellis Pharmaceuticals, Inc. 15 Aug 2022 3 -$80.7K 4 Director 16 Aug 2022, 17:00
APLS Apellis Pharmaceuticals, Inc. 15 Jul 2022 3 -$54.6K 4 Director 18 Jul 2022, 17:29
APLS Apellis Pharmaceuticals, Inc. 15 Jun 2022 3 -$45.8K 4 Director 17 Jun 2022, 17:02
APLS Apellis Pharmaceuticals, Inc. 16 May 2022 3 -$45.6K 4 Director 17 May 2022, 17:26
APLS Apellis Pharmaceuticals, Inc. 14 Apr 2022 3 -$60.3K 4 Director 18 Apr 2022, 19:42
APLS Apellis Pharmaceuticals, Inc. 15 Mar 2022 3 -$46.1K 4 Director 17 Mar 2022, 20:59
APLS Apellis Pharmaceuticals, Inc. 15 Feb 2022 3 -$53.5K 4 Director 16 Feb 2022, 15:29
APLS Apellis Pharmaceuticals, Inc. 14 Jan 2022 3 -$47.4K 4 Director 19 Jan 2022, 19:15
APLS Apellis Pharmaceuticals, Inc. 01 Jan 2022 2 $0 4 Director 04 Jan 2022, 20:28
APLS Apellis Pharmaceuticals, Inc. 31 Dec 2021 1 $0 5 Director 10 Feb 2022, 15:49
APLS Apellis Pharmaceuticals, Inc. 15 Dec 2021 3 -$121K 4 Director 17 Dec 2021, 16:09
APLS Apellis Pharmaceuticals, Inc. 04 Nov 2021 6 -$219K 4 Director 17 Nov 2021, 16:01
APLS Apellis Pharmaceuticals, Inc. 16 Aug 2021 3 -$136K 4 Director 17 Aug 2021, 16:42
APLS Apellis Pharmaceuticals, Inc. 15 Jul 2021 3 -$149K 4 Director 16 Jul 2021, 18:38
APLS Apellis Pharmaceuticals, Inc. 15 Jun 2021 3 -$155K 4 Director 16 Jun 2021, 16:33
APLS Apellis Pharmaceuticals, Inc. 14 May 2021 3 -$107K 4 Director 18 May 2021, 16:05